Aisling Capital Management LP Long-Term Concentrated

Location: New York, NY

CIK: 0001766721 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 3, 2022

Total Value: $151M (100.0% shares, 0.0% debt)

Holdings (17)

BBIO BridgeBio Pharma Inc. (BBIO) 40.1%

Value $60.32M Shares 6,068,125 Est. Cost $40.43 Unrealized -74.3%

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 16.4%

Value $24.63M Shares 1,025,000 Est. Cost $10.24 Unrealized +119.1%

— Verona Pharma plc (VRNA) 9.0%

Value $13.62M Shares 1,332,485 Est. Cost $7.38 Unrealized —

GLUE Monte Rosa Therapeutics Inc. (GLUE) 8.0%

Value $12.03M Shares 1,472,331 Est. Cost $20.37 Unrealized -54.9%

ACRS Aclaris Theraputics Inc. (ACRS) 6.6%

Value $9.986M Shares 634,455 Est. Cost $10.31 Unrealized +52.8%

BMEA Biomea Fusion Inc. (BMEA) 5.2%

Value $7.812M Shares 798,757 Est. Cost $17.65 Unrealized -35.0%

NUVB Nuvation Bio Inc. (NUVB) 3.8%

Value $5.692M Shares 2,541,009 Est. Cost $11.18 Unrealized -74.5%

— Poseida Therapeutics Inc. (PSTX) 2.4%

Value $3.683M Shares 1,043,267 Est. Cost $8.87 Unrealized —

— Elevation Oncology Inc. (ELEV) 2.1%

Value $3.203M Shares 2,834,910 Est. Cost $13.57 Unrealized —

— Reneo Pharmaceuticals Inc. (RPHM) 2.0%

Value $2.968M Shares 886,075 Est. Cost $9.33 Unrealized —

— Spruce Biosciences, Inc. (SPRB) 1.1%

Value $1.652M Shares 1,205,511 Est. Cost $24.31 Unrealized —

— Viracta Therapeutics Inc. (VIRX) 0.8%

Value $1.232M Shares 288,571 Est. Cost $11.34 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 0.8%

Value $1.163M Shares 3,142,857 Est. Cost $4.35 Unrealized —

— Aeglea Biotherapeutics Inc. (AGLE) 0.6%

Value $890K Shares 1,691,151 Est. Cost $8.00 Unrealized —

— AVROBIO, Inc. (AVRO) 0.4%

Value $646K Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Atreca Inc. (BCEL) 0.4%

Value $609K Shares 387,653 Est. Cost $18.84 Unrealized —

— Talaris Therapeutics Inc. (TALS) 0.3%

Value $460K Shares 175,000 Est. Cost $14.69 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$60.32M	40.1%	$40.43	-74.3%	COM	10806X102
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$24.63M	16.4%	$10.24	+119.1%	COM	87164F105
—	Verona Pharma plc (VRNA)	1,332,485	$13.62M	9.0%	$7.38	—	SPONSORED ADS	925050106
GLUE	Monte Rosa Therapeutics Inc. (GLUE)	1,472,331	$12.03M	8.0%	$20.37	-54.9%	COM	61225M102
ACRS	Aclaris Theraputics Inc. (ACRS)	634,455	$9.986M	6.6%	$10.31	+52.8%	COM	00461U105
BMEA	Biomea Fusion Inc. (BMEA)	798,757	$7.812M	5.2%	$17.65	-35.0%	COM	09077A106
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$5.692M	3.8%	$11.18	-74.5%	COM CL A	67080N101
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$3.683M	2.4%	$8.87	—	COM	73730P108
—	Elevation Oncology Inc. (ELEV)	2,834,910	$3.203M	2.1%	$13.57	—	COM	28623U101
—	Reneo Pharmaceuticals Inc. (RPHM)	886,075	$2.968M	2.0%	$9.33	—	COM	75974E103
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$1.652M	1.1%	$24.31	—	COM	85209E109
—	Viracta Therapeutics Inc. (VIRX)	288,571	$1.232M	0.8%	$11.34	—	COM	92765F108
—	Marker Therapeutics, Inc. (MRKR)	3,142,857	$1.163M	0.8%	$4.35	—	COM	57055L107
—	Aeglea Biotherapeutics Inc. (AGLE)	1,691,151	$890K	0.6%	$8.00	—	COM	00773J103
—	AVROBIO, Inc. (AVRO)	1,009,779	$646K	0.4%	$16.72	—	COM	05455M100
—	Atreca Inc. (BCEL)	387,653	$609K	0.4%	$18.84	—	CL A COM	04965G109
—	Talaris Therapeutics Inc. (TALS)	175,000	$460K	0.3%	$14.69	—	COM	87410C104